An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

EBR Systems, backed by investors such as HESTA, Hostplus and private equity veteran Mark Carnegie, can start selling its technology within months.

While training for a half Ironman, Madison DiBattista thought she was in great shape, but she never could have imagined what her body was truly going through.

Discover how cancer treatments impact heart health and learn strategies to mitigate cardiovascular risks during and after ...

Cardiovascular disease is one of the biggest killers in the world, leading to around 18 million deaths a year.

Breakthrough Cardiac Regeneration Research Offers Hope for the Treatment of Ischemic Heart Failure Mar. 7, 2025 — The discovery of a novel approach to promote cardiomyocyte proliferation offers ...

These effects were seen after hydrogel treatment in cultured cells and in a rat model of ischemic heart failure. "The irreversible loss of cardiomyocytes—or heart muscle cells—following ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...